Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Share:
Listens: 0
About
Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial
JAMA Oncology Author Interviews
Miscellaneous
Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial